TUMI Launches Immersive Essentially Beautiful Pop-Up in Seoul

3 years ago

HONG KONG SAR - Media OutReach - 5 July 2023 - TUMI is celebrating its Fall 2023 collection with a…

First Distribution Agreement Executed with Sonic Healthcare

3 years ago

Microba and Sonic Healthcare have now signed a commercial agreement to deliver Microba’s advanced infectious disease testing technology MetaPanelâ„¢ into…

WRISE Group Accelerates Business Momentum with Expansion of Business Footprint and Leadership Capabilities

3 years ago

Launch of WeWrise and VooTech and fresh senior executive leadership appointments all part of an expansion strategy to achieve assets…

InnoCare Announces First Psoriasis Patient Dosed in Clinical Trial of TYK2 Allosteric Inhibitor ICP-488 in China

3 years ago

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases,…

Denodo and Alibaba Cloud Join Forces to Deliver Logical Data Integration and Management to Medium and Large Enterprises Worldwide

3 years ago

Powered by data virtualization, the award winning Denodo Platform is now available on the Alibaba Cloud global Marketplace SINGAPORE--(BUSINESS WIRE)--#cloud--Denodo,…

Nokia and Apple sign long-term patent license agreement

3 years ago

License covers Nokia's (www.Nokia.com) fundamental inventions in 5G and other technologies; Nokia to receive payments from Apple for a multi-year…

Beyond 6000 Puffs, Power Alpha Frees You From the Hassle of Charging

3 years ago

SHENZHEN, China--(BUSINESS WIRE)--SMOORE has gone from strength to strength with its pioneering Power Alpha solution - a charge-free solution offering…

Samsung Partners International Olympic Committee to Present Inaugural Olympic Esports Week in Singapore

3 years ago

SINGAPORE - Media OutReach - 4 July 2023 - At the recently concluded Olympic Esports Week, Samsung Electronics was front…

Galderma @ WCD 2023: Late-Breaking Phase III Results for Nemolizumab Monotherapy in Prurigo Nodularis Show a Significant Proportion of Itch-Free Patients by Week 4

3 years ago

Latest data from the phase III OLYMPIA 2 trial presented at the World Congress of Dermatology (WCD) showcase rapid onset…

Spesolimab prevents generalized pustular psoriasis flares in EFFISAYILâ„¢ 2 trial

3 years ago

Data demonstrate superiority vs. placebo in preventing generalized pustular psoriasis (GPP) flares up to 48 weeks1 Prevention of unpredictable flares…